{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:51:36Z","timestamp":1792119096434,"version":"4.4.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.tips.2007.12.005","type":"journal-article","created":{"date-parts":[[2008,2,13]],"date-time":"2008-02-13T09:56:59Z","timestamp":1202896619000},"page":"109-115","source":"Crossref","is-referenced-by-count":135,"title":["Drugs for relapse prevention of alcoholism: ten years of progress"],"prefix":"10.1016","volume":"29","author":[{"given":"Rainer","family":"Spanagel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Falk","family":"Kiefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2007.12.005_bib1","unstructured":"World Health Organization (2004) Global Status Report on Alcohol 2004, World Health Organization (http:\/\/www.who.int\/substance_abuse\/publications\/global_status_report_2004_overview.pdf)}"},{"key":"10.1016\/j.tips.2007.12.005_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2007.12.005_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0893-133X(98)00084-0","article-title":"Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat","volume":"20","author":"Katner","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2007.12.005_bib4","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/sj.npp.1300657","article-title":"The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behaviour","volume":"30","author":"Bachteler","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2007.12.005_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1369-1600.2006.00012.x","article-title":"Behavioral assessment of drug-reinforcement and addictive features in rodents: an overview","volume":"11","author":"Sanchis-Segura","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2007.12.005_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0165-6147(97)89800-8","article-title":"Anti-craving compounds: new pharmacological tools to study addictive processes","volume":"18","author":"Spanagel","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2007.12.005_bib7","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1369-1600.2005.00029.x","article-title":"The alcohol-preferring P rat and animal models of excessive alcohol drinking","volume":"11","author":"Bell","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2007.12.005_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1369-1600.2006.00038.x","article-title":"Alcohol-related genes: contributions from studies with genetically engineered mice","volume":"11","author":"Crabbe","year":"2006","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2007.12.005_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-006-0592-z","article-title":"Ethanol self-administration and reinstatement of ethanol-seeking behavior in Per1(Brdm1) mutant mice","volume":"190","author":"Zghoul","year":"2007","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2007.12.005_bib10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.alcohol.2006.12.003","article-title":"Characterization of the ethanol-deprivation effect in substrains of C57BL\/6 mice","volume":"40","author":"Khisti","year":"2006","journal-title":"Alcohol"},{"key":"10.1016\/j.tips.2007.12.005_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001867.pub2","article-title":"Opioid antagonists for alcohol dependence","author":"Srisurapanont","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2007.12.005_bib12","first-page":"1386","article-title":"Naltrexone's effect on cue-elicited craving among alcoholics in treatment","volume":"23","author":"Monti","year":"1999","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.tips.2007.12.005_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling","volume":"163","author":"Grant","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tips.2007.12.005_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1369-1600.2007.00073.x","article-title":"Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone","volume":"13","author":"Kiefer","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2007.12.005_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0893-133X(99)00024-X","article-title":"Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress","volume":"21","author":"L\u00ea","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2007.12.005_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.npp.1301438","article-title":"Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence","volume":"33","author":"Walker","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2007.12.005_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002130000601","article-title":"Kappa-opioid receptors and relapse-like drinking in long-term ethanol experienced rats","volume":"153","author":"H\u00f6lter","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2007.12.005_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tins.2007.06.006","article-title":"A key role for corticotropin-releasing factor in alcohol dependence","volume":"30","author":"Heilig","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2007.12.005_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00213-003-1645-1","article-title":"Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin\/orphanin FQ in alcohol-preferring rats","volume":"172","author":"Ciccocioppo","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2007.12.005_bib20","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/00001756-200006260-00026","article-title":"Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats","volume":"11","author":"Martin-Fardon","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.tips.2007.12.005_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.biopsych.2006.01.006","article-title":"Buprenorphine reduces alcohol drinking through activation of the nociceptin\/orphanin FQ-NOP receptor system","volume":"61","author":"Ciccocioppo","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2007.12.005_bib22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2007.12.005_bib23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.npp.1301169","article-title":"The nociceptin\/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking","volume":"32","author":"Kuzmin","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2007.12.005_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1369-1600.2007.00089.x","article-title":"Association between the nociceptin receptor gene (OPRL1) single nucleotide polymorphisms and alcohol dependence","volume":"13","author":"Huang","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2007.12.005_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.ALC.0000108656.81563.05","article-title":"The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis","volume":"28","author":"Mann","year":"2004","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.tips.2007.12.005_bib26","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.295.17.2003","article-title":"Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial","volume":"295","author":"Anton","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2007.12.005_bib27","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jama.296.14.1727-b","article-title":"Pharmacotherapy and behavioral intervention for alcohol dependence","volume":"296","author":"Kiefer","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2007.12.005_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm1163","article-title":"The circadian clock gene Period2 alters the glutamatergic system and thereby modulates alcohol consumption","volume":"11","author":"Spanagel","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2007.12.005_bib29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bcp.2007.06.039","article-title":"Glutamatergic substrates of drug addiction and alcoholism","volume":"75","author":"Gass","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tips.2007.12.005_bib30","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuropharm.2005.01.002","article-title":"The role of the NMDA receptor complex in alcohol relapse: A pharmacological mapping study using the alcohol deprivation effect","volume":"48","author":"Vengeliene","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.tips.2007.12.005_bib31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1176\/appi.ajp.164.3.519","article-title":"Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients","volume":"164","author":"Krupitsky","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.tips.2007.12.005_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nature715","article-title":"Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits","volume":"415","author":"Chatterton","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.tips.2007.12.005_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.schres.2004.02.016","article-title":"NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder","volume":"71","author":"Mueller","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.tips.2007.12.005_bib34","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1523\/JNEUROSCI.4237-05.2006","article-title":"Involvement of AMPA receptor GluR-C subunit in alcohol-seeking and relapse","volume":"26","author":"Sanchis-Segura","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2007.12.005_bib35","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(03)13370-3","article-title":"Oral topiramate for treatment of alcohol dependence: a randomised controlled trial","volume":"361","author":"Johnson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2007.12.005_bib36","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1001\/jama.298.14.1641","article-title":"Topiramate for treating alcohol dependence: a randomized controlled trial","volume":"298","author":"Johnson","year":"2007","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.tips.2007.12.005_bib37","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.npp.1300381","article-title":"MPEP reduces ethanol-seeking and relapse behavior","volume":"29","author":"Backstr\u00f6m","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2007.12.005_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00213-005-2175-9","article-title":"The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats","volume":"179","author":"Schroeder","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2007.12.005_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/13556210500223132","article-title":"The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system","volume":"10","author":"Cowen","year":"2005","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2007.12.005_bib40","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1523\/JNEUROSCI.2384-06.2006","article-title":"Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala","volume":"26","author":"Zhao","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2007.12.005_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/nm1632","article-title":"Activation of mGlu2\/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial","volume":"13","author":"Patil","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2007.12.005_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(99)01447-2","article-title":"The dopamine hypothesis of reward: past and current status","volume":"22","author":"Spanagel","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.tips.2007.12.005_bib43","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1124\/jpet.300.3.882","article-title":"Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats","volume":"300","author":"Liu","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tips.2007.12.005_bib44","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1096\/fj.06-6110com","article-title":"The D3 receptor plays an essential role in alcohol craving and relapse but not in alcohol reinforcement processes","volume":"20","author":"Vengeliene","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2007.12.005_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1369-1600.2007.00051.x","article-title":"Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behaviour in mice","volume":"12","author":"Heidbreder","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.tips.2007.12.005_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.brainresrev.2004.12.033","article-title":"The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence","volume":"49","author":"Heidbreder","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.tips.2007.12.005_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biopsych.2007.04.026","article-title":"Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use","volume":"63","author":"Blomeyer","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2007.12.005_bib48","doi-asserted-by":"crossref","first-page":"15236","DOI":"10.1073\/pnas.0604419103","article-title":"Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress","volume":"103","author":"Hansson","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2007.12.005_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biopsych.2005.11.023","article-title":"Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anti-craving treatment?","volume":"60","author":"Kiefer","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tips.2007.12.005_bib50","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1523\/JNEUROSCI.23-06-02453.2003","article-title":"A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking","volume":"23","author":"Racz","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2007.12.005_bib51","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00213-005-0199-9","article-title":"Effect of the cannabinoid CB1 receptor antagonist SR141716A on ethanol self-administration and ethanol-seeking behaviour in rats","volume":"183","author":"Economidou","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.tips.2007.12.005_bib52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/alcalc\/agh114","article-title":"Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats","volume":"40","author":"Gessa","year":"2005","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.tips.2007.12.005_bib53","first-page":"CD005353","article-title":"Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation","volume":"18","author":"Cahill","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.tips.2007.12.005_bib54","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.64.3.369","article-title":"Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques","volume":"64","author":"Barr","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2007.12.005_bib55","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/sj.npp.1300219","article-title":"A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients","volume":"28","author":"Oslin","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.tips.2007.12.005_bib56","unstructured":"Anton, R. et al. Variation in the mu-opiate receptor gene (OPRM1) predicts response to naltrexone: results from the combine study. Arch. Gen. Psychiatry (in press)"},{"key":"10.1016\/j.tips.2007.12.005_bib57","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1139","article-title":"Protein microarrays for multiplex analysis of signal transduction pathways","volume":"10","author":"Chan","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2007.12.005_bib58","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.62.1.57","article-title":"Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil","volume":"62","author":"Heinz","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2007.12.005_bib59","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/nrn1993","article-title":"Intermediate phenotypes and genetic mechanisms of psychiatric disorders","volume":"7","author":"Meyer-Lindenberg","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2007.12.005_bib60","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1371\/journal.pmed.0030209","article-title":"The clinical applications of a systems approach","volume":"3","author":"Ahn","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.tips.2007.12.005_bib61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.60.1.92","article-title":"Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study","volume":"60","author":"Kiefer","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.tips.2007.12.005_bib62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/alcalc\/agl007","article-title":"Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centre's experience with pharmacotherapy","volume":"41","author":"Feeney","year":"2006","journal-title":"Alcohol Alcohol."},{"key":"10.1016\/j.tips.2007.12.005_bib63","unstructured":"Karpyak, V.M. et al. Alcoholism treatment with naltrexone and acamprosate: what can influence the outcome. Addiction (in press)"},{"key":"10.1016\/j.tips.2007.12.005_bib64","series-title":"Drugs for Relapse Prevention of Alcoholism","year":"2005"},{"key":"10.1016\/j.tips.2007.12.005_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/alcalc\/agh067","article-title":"Challenges to medications development in treating alcohol dependence: an international perspective","volume":"39","author":"Littleton","year":"2004","journal-title":"Alcohol Alcohol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614708000229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614708000229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T21:35:46Z","timestamp":1557264946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614708000229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0165614708000229"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2007.12.005","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}